A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Glatiramer Acetate 20 mg in Patients with Remitting Multiple Sclerosis: First-Year Study Results
Titel:
A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Glatiramer Acetate 20 mg in Patients with Remitting Multiple Sclerosis: First-Year Study Results
Auteur:
Boiko, A. N. Lashch, N. Yu. Sharanova, S. N. Zakharova, M. N. Trifonova, O. V. Simaniv, T. O. Lysogorskaya, E. V. Gur’yanova, O. E. Kotov, S. V. Yakushina, T. I. Lizhdvoi, V. Yu. Belova, Yu. A. Khabirov, F. A. Babicheva, N. N. Khaibullin, T. I. Granatov, E. V. Aver’yanova, L. A. Sazonov, D. V. Odinak, M. M. Trinitatskii, Yu. V. Tsukurova, L. A. Sergeeva, A. I. Ivanov, R. A. Shustova, M. S.